For Some AFib Patients, Lasting Relief Takes Specialty Care

Originally published November 17, 2026

Last updated November 17, 2026

Reading Time: 4 minutes

Doctor consults in office with patient with AFib abnormal heartbeat symptoms.

For some patients suffering from longstanding persistent AFib, a new model of care provides hope.

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, or irregular heartbeat, in the United States. Approximately 5% of U.S. adults, up to 12 million people, suffer from AFib. Patients with AFib may experience heart palpitations, dizziness, lightheadedness, shortness of breath, chest pain and fatigue. AFib is likelier to occur as people age.

While advanced medical and interventional treatments have helped control and even cure the disease in some, these treatments are not necessarily effective for all AFib patients.

Now, however, a new advanced multidisciplinary AFib clinic at Keck Medicine of USC – Pasadena, located at 590 S. Fair Oaks Ave., helps bridge that gap.

Different types of AFib

There are several types of AFib. One is paroxysmal AFib, when arrhythmia symptoms occur for less than a week or so and then stop, either on their own or with intervention, for a stretch of time. These arrhythmias originate around the myocardial muscle sleeves, extending into the pulmonary veins within the heart’s left atrium. 

Physicians often treat paroxysmal AFib with medication or with endocardial ablation treatments such as cryoablation, radiofrequency ablation and pulsed field ablation. Endocardial ablation is usually performed by a cardiac electrophysiologist. These procedures create scar tissue on veins or muscle tissue inside the heart in order to hinder the abnormal electrical signals causing the arrhythmia. As opposed to open surgery, endocardial ablation is minimally invasive, meaning physicians can perform them through small incisions in the body as opposed to large incisions. 

Another type of AFib is longstanding persistent AFib, which lasts more than seven days but less than a year. Symptomatic longstanding persistent AFib accounts for about 10%-20% of AFib cases. For patients with longstanding persistent AFib, the treatments mentioned above often aren’t effective.

Jonathan Praeger, MD, a cardiothoracic surgeon with the USC Cardiac and Vascular Institute, part of Keck Medicine of USC, explains that partly due to factors related to the architecture of the left atrium, in patients with longstanding persistent AFib, “the arrhythmia isn’t just around those pulmonary veins. We often see fibrosis (excessive buildup of fibrous connective tissue) and scarring with these patients that create the perfect setup for the self-sustaining electrical loops that maintain the AFib.”

Commonly, neither medication nor endocardial ablation work to keep patients out of longstanding persistent AFib. In these cases, surgery may be needed.

Patient-specific care plans for AFib

At the Keck Medicine of USC – Pasadena location at 590 S. Fair Oaks Ave., cardiovascular experts are taking a new hybrid approach to treating AFib patients, including those with symptomatic longstanding persistent AFib. This new advanced multidisciplinary clinic for AFib is led by Dr. Praeger and Ivan C. Ho, MD, director of cardiac electrophysiology for the USC Cardiac and Vascular Institute.

“When patients visit the clinic,” Dr. Ho explains, “they meet with a cardiac electrophysiologist, a cardiac surgeon and a nurse practitioner all in one visit to discuss options. The goal is to fully evaluate each patient’s AFib risk factors, their treatment history — including treatment failures — and any cardiac abnormalities or other noncardiac comorbidities. Then we build the best treatment plan for them, whether that’s endocardial, surgical or both.”

Depending on the patient, a treatment plan may need to include minimally invasive endocardial ablation from an electrophysiologist like Dr. Ho as well as minimally invasive epicardial surgery from a cardiac surgeon like Dr. Praeger.

As opposed to endocardial ablation, a cardiac surgeon performs epicardial ablation on the heart muscle tissue from outside the heart. Again, this procedure is minimally invasive. An ablation device is inserted into the pericardial space to target the origin of the arrythmia.

The Pasadena clinic’s cardiac surgeons and electrophysiologists integrate their respective interventional expertise to offer both minimally invasive surgical treatments like convergent maze and totally thoracoscopic maze (TT-maze) as well as postsurgical electrophysiologic evaluation using the latest endocardial ablation technologies.

An advanced model of care for AFib

The goal is to optimize outcomes for a patient’s specific AFib condition, especially those with longstanding persistent AFib.

“We take care of the patient as a team,” Dr. Praeger says. “It’s tailored, it’s collaborative and it offers patients procedures they can’t access everywhere, like TT-maze.”

Among those who could benefit from the clinic’s specialized services are patients with longstanding persistent AFib, a history of multiple unsuccessful catheter ablations, advanced heart failure or a need for concurrent cardiac procedures like CABG or valve repair, among other criteria.

As Dr. Ho puts it, “If someone’s already had 15 years of atrial fibrillation and two cardiac ablations and they’re still symptomatic, I want that patient to get the right care. They need to know that this clinic exists.”

Dr. Praeger agrees. “We gear everything toward doing what’s right for the patient,” he says. “Longstanding persistent AFib can really hinder patients’ lives. But when we get them out of AFib, they can live a normal life. It’s such a dramatic improvement. So, the more that people know about what we do, the fewer will fall through the gap.”

Connect with Our Team

Our experts excel at treating complex AFib cases such as longstanding persistent AFib, coordinating treatment across cardiology, electrophysiology and cardiac surgery.
Learn More

Topics

Jennifer Grebow, manager of editorial services, Keck Medicine of USC.
Jennifer Grebow
Jennifer Grebow is manager of editorial services for Keck Medicine of USC.